Google
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Freda Lewis-Hall and TLC’s “T-Boz” Discuss Sickle Cell Disease on The Doctors
Dr. Freda Lewis-Hall, chief medical officer of Pfizer, appears on The Doctors to speak about sickle cell disease, a blood disorder that primarily affects African Americans, and the genetic trait linked to the disease. She and The Doctors are joined by Tionne “T-Boz” Watkins, of the musical group TLC, who lives with the condition. Check your local listings to see the whole show and learn more at www.GetHealthyStayHealthy.com.
+myBinderRelated Content
-
10th Annual Sickle Cell Disease Therapeutics Conference – VirtualThe Annual Sickle Cell Disease Therapeut...
-
Finding the right sickle cell disease care teamChandra Wallace does not remember a time...
-
Onyinye Onyekwere, MDDr. Onyinye Onyekwere is a pediatric hem...
-
Cognitive behavioral therapy in patients with sickle cell diseaseIntroduction: Sickle cell disease (SCD) ...
-
Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and strokeParadoxical' embolization via intracardi...
-
The Empowered Caregivers Forum: A Support Resource for Parents / Caregivers of Warriors With Sickle Cell / Thalassem...Join Carla Lewis, CEO of Kids Conquering...
-
Students With Sickle Cell Disease Stay on Track With Help From St. Louis Children’s HospitalBrandon Gardner graduated Friday on sche...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
